small cell lung cancer treated with erlotinib heterogeneity

association between single nucleotide polymorphisms (snps) and toxicity of advanced non-small-cell lung cancer patients treated with chemotherapy单核苷酸多态性(snp)之间的联系和毒性的晚期非小细胞肺癌患者接受化疗.pdf Association between Single Nucleotide Polymorphisms (SNPs) and Toxicity of Advanced Non-Small-Cell Lung Cancer Patients Treated with Chemotherapy . . Ling Zhang , Guanghui Gao , Xuefei Li, Shengxiang Ren, Aiwu Li, Jianfang Xu, Jie Zhan

2017-08-27 约5.46万字 6页立即下载

efficacy and safety of neoadjuvant 1 blockade with sintilimab resectable non small cell lung cancer新辅助与Sintilimab在可切除非小细胞肺癌效安全性.pdf EfficacyandSafetyofNeoadjuvantPD-1 BlockadewithSintilimabinResectable Non-SmallCellLungCancer(NSCLC) 1111111111111 N.Li,J.Ying,X.Tao,F.Zhang,Z.Zhao,Y.Ling,Y.Gao,J.Zhao,Q.Xue,Y.Mao,W.Lei,N.Wu,S.Wang, 111112211 J.Duan,Y.Gao,Z.Wang,N.Sun,J.Wang,H.Zhou,S.Wang,S.Gao,J.He 1NationalCancerCenter/NationalCli

2025-04-06 约1.46万字 16页立即下载

combination treatment with mek and akt inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivomek和akt抑制剂联合治疗更有效比每种药物单独使用人类非小细胞肺癌在体外和体内.pdf Combination Treatment with MEK and AKT Inhibitors Is More Effective than Each Drug Alone in Human Non- Small Cell Lung Cancer In Vitro and In Vivo 1 1 1 2 3

2017-09-08 约5.92万字 10页立即下载

efficacy and safety of sintilimab with anlotinib as first-line therapy for advanced non small cell lung cancer用Anlotinib作为晚期非小细胞肺癌NSCLC一线疗法功效安全性.pdf Efficacyandsafetyofsintilimabwithanlotinib asfirst-linetherapyforadvancednon-smallcell lungcancer(NSCLC) 1*11111 BaohuiHan,TianqingChu,RunboZhong,HuaZhong,BoZhang,WeiZhang,Chunlei 111 Shi,JialinQian,YuchenHan 1.ShanghaiChestHospital,ShanghaiJiaotongUniversity,Shanghai,;*Correspondingauthor BaohuiHan

2025-04-04 约1.97万字 16页立即下载

小细胞肺癌（small cell lung cancer）.doc 小细胞肺癌（small cell lung cancer） Type Small cell lung cancer is one of the basic types of lung cancer. It belongs to undifferentiated carcinoma, and its pathological types include oat cell type, intermediate cell type and mixed oat cell type. 1/5 of lung cancer patients belong to this type. Small cell

2017-09-04 约3.13万字 25页立即下载

非小细胞肺癌分子靶向治疗的护理进展（Advances in molecular targeted therapy for non-small cell lung cancer）.doc 非小细胞肺癌分子靶向治疗的护理进展（Advances in molecular targeted therapy for non-small cell lung cancer） Non small cell lung cancer molecular targeted therapy in nursing The chief medical network in 2011 09 months 11 days 16:26:09 Sunday [Abstract] in non-small cell lung cancer molecular target to review the nursin

2017-07-30 约1.67万字 12页立即下载

clinicalof osimertinib responder small cell lung cancer patients with egfr t790m临床反应在非小细胞肺癌患者EGFR T790M突变中.pdf Clinicalcharacteristicsofosimertinib responderinnon-smallcelllungcancer patientswithEGFR-T790Mmutation 1123 T.Yamada,A.Yoshimura,T.Takeda,S.Shiotsu, 4511 O.Hiranuma,Y.Chihara,J.Uchino,K.Takayama 12 KyotoPrefecturalUniversityofMedicine,Kyoto/Japan,Japanese 3 RedCrossKyotoDainiHospital,Kyoto/Japan,Jap

2025-03-28 约1.32万字 15页立即下载

非小细胞肺癌18F - FDG PET图像异质性：靶区勾画影响与预后价值探究.docx 非小细胞肺癌18F-FDGPET图像异质性：靶区勾画影响与预后价值探究一、引言 1.1研究背景肺癌作为全球范围内发病率和死亡率均居高不下的恶性肿瘤，严重威胁着人类的生命健康。据世界卫生组织国际癌症研究机构（IARC）发布的2020年全球癌症负担数据显示，肺癌的新发病例数达220万，死亡病例数为180万，分别位居恶性肿瘤的第二位和第一位。非小细胞肺癌（non-smallcelllungcancer，NSCLC）是肺癌的主要类型，约占所有肺癌病例的80%-85%，其主要包括腺癌、鳞状细胞癌和大细胞癌等亚型。由于NSCLC早期症状隐匿，多数患者确诊时已处

2025-05-19 约2.72万字 21页立即下载

bioluminescent orthotopic mouse models of human localized non-small cell lung cancer feasibility and identification of circulating tumour cells生物荧光原位人类局部非小细胞肺癌小鼠模型可行性和循环肿瘤细胞的识别.pdf Bioluminescent Orthotopic Mouse Models of Human Localized Non-Small Cell Lung Cancer: Feasibility and Identification of Circulating Tumour Cells 1,2. 1,3. 1 2 ` 2

2017-08-27 约6.91万字 9页立即下载

18F-FDG PET-CT显像预测非小细胞肺癌免疫治疗疗效的价值研究.docx 18F-FDGPET-CT显像预测非小细胞肺癌免疫治疗疗效的价值研究 18F-FDGPET-CT显像预测非小细胞肺癌免疫治疗疗效的价值研究摘要：本研究旨在探讨18F-FDGPET/CT显像在预测非小细胞肺癌（NSCLC）免疫治疗疗效方面的价值。通过对比分析18F-FDGPET/CT显像与免疫治疗效果的关联性，为临床提供更准确的预测工具，以指导免疫治疗方案的制定和调整。一、引言 非小细胞肺癌（NSCLC）是肺癌的主要类型，其治疗方式多样，包括手术、放疗、化疗及免疫治疗等。随着免疫治疗在NSCLC中的广泛应用，如何准确评估治疗效果成为临床关注的重点。18F-FDGPET/CT显像作为

2025-02-04 约4.31千字 8页立即下载

18F-FDG PET_CT预测非小细胞肺癌免疫治疗疗效的研.docx 18F-FDGPET/CT预测非小细胞肺癌免疫治疗疗效的研究进展王思思郑勇董科 [关键词]?18F-FDG?PET/CT；非小细胞肺癌；免疫治疗；影像组学；疗效 [中图分类号]?R734.2??????[文献标识码]?A????[DOI]?10.3969/j.issn.1673-9701.2024.12.028 正电子发射计算机体层显像仪（positron?emission?tomography?and?computed?tomography，PET/CT）是一项将解剖定位与功能成像相结合，用于精准预测疗效的影像学检查方法。18F-氟代脱氧葡萄糖（18F-fluorode-oxyglucos

2025-04-18 约4.65千字 5页立即下载

18F-FDG PET-CT显像预测非小细胞肺癌免疫治疗疗效的价值研究.docx 18F-FDGPET-CT显像预测非小细胞肺癌免疫治疗疗效的价值研究 18F-FDGPET-CT显像预测非小细胞肺癌免疫治疗疗效的价值研究摘要：本研究旨在探讨18F-FDGPET/CT显像在预测非小细胞肺癌（NSCLC）免疫治疗疗效方面的价值。通过对比分析，我们发现18F-FDGPET/CT在监测免疫治疗效果和评估肿瘤响应方面具有较高的准确性，可有效预测患者的治疗效果和生存情况，为临床提供有力依据。一、引言：随着免疫治疗在非小细胞肺癌（NSCLC）治疗中的广泛应用，准确评估治疗效果成为研究热点。18F-FDGPET/CT作为一种功能显像技术，能够非侵入性地评估肿瘤的代谢活动和治疗效果。本

2025-05-03 约4.88千字 9页立即下载

肺癌的诊断治疗进展Advances in the Management of Non Small Cell Lung Cancer.ppt * * ADDITIONAL INFORMATION KEY POINT: * Computer-Generated Tri-Dimensional Structure of the EGFR-ATP Binding Site In the above picture the inhibitor gefitinib occupies the adenosine triphosphate (ATP) cleft The two missense mutations are shown within the activating loop of the tyrosine kinase

2018-08-15 约2.74万字 53页立即下载

stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors the egfr fluorescence in situ hybridization assay分层治疗非小细胞肺癌病人的表皮生长因子受体抑制剂的表皮生长因子受体荧光原位杂交试验.pdf Diagnostic Pathology BioMed Central Methodology Open Access Stratifi

2017-09-10 约7.22万字 10页立即下载

Association between Promoter Methylation and Non- Small Cell Lung Cancer A Meta-Analysis.pdf Association between P16INK4a Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis Jundong Gu1,5., Yanjun Wen2., Siwei Zhu3, Feng Hua4, Hui Zhao5, Hongrui Xu5, Jiacong You1, Linlin Sun1, Weiqiang Wang1, Jun Chen1, Qinghua Zhou1* 1 Tianjin Key Laboratory of Lung Cancer Metastasis and T

2017-04-08 约3.67万字 10页立即下载

small cell lung cancer treated with erlotinib heterogeneity of 18f fdg uptake pet association treatment response and prognosis在宠物关联时用Erlotinib heteronib摄取治疗反应预后非小细胞肺癌.pdf